Search Results for:
INTROPY: A new approach to cancer therapy by inhibiting mechanotransduction
IBEC senior researcher Pere Roca-Cusachs has been awarded an ERC Proof of Concept Grant. This is a prestigious grant awarded by the European Research Council to explore the commercial and societal potential of research projects carried out at European institutions. Roca-Cusachs’ project, INTROPY, focuses on the inhibition of mechanotransduction as a potential therapy against cancer or fibrosis.
Artificial Intelligence for Bioengineering (NET-IA)
This network’s aim is to equip IBEC researchers with knowledge about the latest machine learning (ML) techniques for bioengineering and create a specialized ML toolkit tailored for IBEC’s needs. Key focus … Read more
Printing proteins to recreate the gut in the lab
An IBEC-led study describes the development of an innovative method to control the formation of crypt-like structures and villi in the intestine using a contact protein printing technique. This model will make it possible to study in detail key processes such as cell regeneration or changes associated with diseases such as cancer and chronic inflammatory disorders.